No Data
No Data
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Anebulo Pharmaceuticals Collaborates With FDA to Advance Selonabant
Express News | Anebulo Pharmaceuticals: Intends to Modify Loan and Security Agreement by Reducing Maximum Loan Size to About $3 Mln
Express News | Anebulo Pharmaceuticals: Entered Stock Purchase Agreement for Issuance & Sale of 15.2 Mln Shares of Common Stock for $15 Mln
Anebulo Pharmaceuticals Announces FDA Feedback For IV Selonabant To Address Cannabis-Induced Toxicity In Children And Completes $15M Capital Raise; Phase I Study Planned For 1H25
Express News | Anebulo Pharmaceuticals Inc: Plans to Begin Its Phase I Sad Study of IV Selonabant in Healthy Adults in 1H25